These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 19800951

  • 1. Comparative biochemical and pharmacological characterization of a novel, NOP receptor selective hexapeptide, Ac-RYYRIR-ol.
    Bojnik E, Babos F, Fischetti C, Magyar A, Camarda V, Borsodi A, Bajusz S, Calo' G, Benyhe S.
    Brain Res Bull; 2010 Mar 16; 81(4-5):477-83. PubMed ID: 19800951
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol.
    Gündüz O, Rizzi A, Baldisserotto A, Guerrini R, Spagnolo B, Gavioli EC, Kocsis L, Magyar A, Benyhe S, Borsodi A, Calò G.
    Eur J Pharmacol; 2006 Jun 06; 539(1-2):39-48. PubMed ID: 16682024
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24.
    Fischetti C, Camarda V, Rizzi A, Pelà M, Trapella C, Guerrini R, McDonald J, Lambert DG, Salvadori S, Regoli D, Calo' G.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):50-7. PubMed ID: 19445927
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.
    J Pharmacol Exp Ther; 2007 Jun 01; 321(3):961-7. PubMed ID: 17329552
    [Abstract] [Full Text] [Related]

  • 5. In vitro binding and functional studies of Ac-RYYRIK-ol and its derivatives, novel partial agonists of the nociceptin/orphanin F/Q receptor.
    Gunduz O, Sipos F, Spagnolo B, Kocsis L, Magyar A, Orosz G, Borsodi A, Calò G, Benyhe S.
    Neurosignals; 2007 Jun 01; 15(2):91-101. PubMed ID: 16874009
    [Abstract] [Full Text] [Related]

  • 6. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec 01; 378(6):553-61. PubMed ID: 18807245
    [Abstract] [Full Text] [Related]

  • 7. [Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonist.
    Molinari S, Camarda V, Rizzi A, Marzola G, Salvadori S, Marzola E, Molinari P, McDonald J, Ko MC, Lambert DG, Calo' G, Guerrini R.
    Br J Pharmacol; 2013 Jan 01; 168(1):151-62. PubMed ID: 22827708
    [Abstract] [Full Text] [Related]

  • 8. Selective and high affinity labeling of neuronal and recombinant nociceptin receptors with the hexapeptide radioprobe [(3)H]Ac-RYYRIK-ol.
    Bojnik E, Farkas J, Magyar A, Tömböly C, Güçlü U, Gündüz O, Borsodi A, Corbani M, Benyhe S.
    Neurochem Int; 2009 Dec 01; 55(7):458-66. PubMed ID: 19414055
    [Abstract] [Full Text] [Related]

  • 9. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 01; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 01; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 11. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 01; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes.
    Johnson EE, McDonald J, Nicol B, Guerrini R, Lambert DG.
    Brain Res; 2004 Apr 02; 1003(1-2):18-25. PubMed ID: 15019559
    [Abstract] [Full Text] [Related]

  • 14. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G.
    Peptides; 2009 Feb 02; 30(2):248-55. PubMed ID: 18992780
    [Abstract] [Full Text] [Related]

  • 15. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.
    Ferrari F, Cerlesi MC, Malfacini D, Asth L, Gavioli EC, Journigan BV, Kamakolanu UG, Meyer ME, Yasuda D, Polgar WE, Rizzi A, Guerrini R, Ruzza C, Zaveri NT, Calo G.
    Eur J Pharmacol; 2016 Dec 15; 793():1-13. PubMed ID: 27780725
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides.
    Erdei AI, Borbély A, Magyar A, Szűcs E, Ötvös F, Gombos D, Al-Khrasani M, Stefanucci A, Dimmito MP, Luisi G, Mollica A, Benyhe S.
    Peptides; 2019 Feb 15; 112():106-113. PubMed ID: 30513351
    [Abstract] [Full Text] [Related]

  • 17. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J, Calo G, Guerrini R, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb 15; 367(2):183-7. PubMed ID: 12595960
    [Abstract] [Full Text] [Related]

  • 18. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.
    J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity studies on high affinity NOP-active hexapeptides.
    Judd AK, Tuttle DJ, Jones RW, Sanchez A, Polgar W, Berzetei-Gurske I, Toll L.
    J Pept Res; 2004 Sep 10; 64(3):87-94. PubMed ID: 15317498
    [Abstract] [Full Text] [Related]

  • 20. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J, Barnes TA, Calo G, Guerrini R, Rowbotham DJ, Lambert DG.
    Eur J Pharmacol; 2002 May 17; 443(1-3):7-12. PubMed ID: 12044785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.